Gene · 10683
Papers2,335
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,335
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activated notch signaling pathway protects the intestinal barrier in DSS-induced colitis by regulating tight junctions. | Eur J Med Res | 2026 | 41572387 | PubTator, text mining | PubMed |
| [Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]. | Aktuelle Urol | 2026 | 41571001 | PubTator, text mining | PubMed |
| c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. | Cell Rep Med | 2026 | 41564857 | PubTator, text mining | PubMed |
| Updates on Antibody Drug Conjugates and Bispecific T-Cell Engagers in SCLC. | Antibodies (Basel) | 2026 | 41562777 | PubTator, text mining | PubMed |
| Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy. | Antib Ther | 2026 | 41561192 | PubTator, text mining | PubMed |
| Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use. | Clin Lung Cancer | 2026 | 41544604 | PubTator, text mining | PubMed |
| The making of multispecific immunoglobulins - a clinical perspective. | MAbs | 2026 | 41542910 | PubTator, text mining | PubMed |
| Molecular decoupling of lineage identity and morphology in aggressive variant prostate cancer. | medRxiv | 2026 | 41542660 | PubTator, text mining | PubMed |
| Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab. | Cancer Discov | 2026 | 41532856 | PubTator, text mining | PubMed |
| Spondylocostal Dysostosis-1 Associated With Pancreatic Heterotopia: Coincidence or True Association? | Pediatr Dev Pathol | 2026 | 41527833 | PubTator, text mining | PubMed |
| Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours. | Histopathology | 2026 | 41489019 | PubTator, text mining | PubMed |
| Molecular alteration profiles characterize intraductal carcinoma of the prostate. | Cancer | 2026 | 41457395 | PubTator, text mining | PubMed |
| ADC for SCLC Clears Phase I. | Cancer Discov | 2026 | 41405207 | PubTator, text mining | PubMed |
| Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells. | MAbs | 2026 | 41383027 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in lung cancer: current landscape and future perspectives. | Curr Opin Oncol | 2026 | 41222552 | PubTator, text mining | PubMed |
| Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer. | Mol Cancer Ther | 2026 | 41041866 | PubTator, text mining | PubMed |
| A Confirmatory Case of Severe Spondylocostal Dysostosis Caused by Biallelic Loss-of-Function of DMRT2. | Am J Med Genet A | 2026 | 41014130 | PubTator, text mining | PubMed |
| CAR-T therapy: Advances in respiratory diseases. | Chin Med J Pulm Crit Care Med | 2025 | 41551012 | PubTator, text mining | PubMed |
| The Olive Phenolic S-(-)-Hydroxyoleocanthal Attenuates Neuroendocrine Prostate Cancer via Modulation of EPHA3-Centered Oncogenic Network. | Cancers (Basel) | 2025 | 41514539 | PubTator, text mining | PubMed |
| CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level. | bioRxiv | 2025 | 41446220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10683/papers?page=8